p27Kip1 expression and grading of breast cancer diagnosed on cytological samples

Diagnostic Cytopathology

Volumn 30, Issue 6, 2004, Pages 375-380

  Troncone, Giancarlo ^a   Migliaccio, Ilenia ^a   Caleo, Alessia ^a   Palmieri, Emiliano A ^a   Iaccarino, Antonino ^a   Sparano, Lucianna ^a   Vetrani, Antonio ^a   Palombini, Lucio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Breast cancer; Breast cytology; Cytological grading; P27Kip1

Indexed keywords

PROTEIN P27;

ADULT; ARTICLE; ASPIRATION CYTOLOGY; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTODIAGNOSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 2942718764     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20059     Document Type: Article

References (25)

1. Palombini L, Fulciniti F, Vetrani A, et al. Fine-needle aspiration biopsy of the breast masses: a critical analysis of 1956 cases in 8 years (1976-1984). Cancer 1988;61:2773-2777.
2. Lloyd RV, Erickson LA. P27/kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;54:313-323.
3. Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell cycle regulators p27/kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997;3:222-225.
4. Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased levels of cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med 1997;3:227-230.
5. Tan P, Cady B, Wanner M, et al. The cell cycle inhibitor p27 is an indipendent prognostic marker in small (T1a, b) invasive breast carcinomas. Cancer Res 1997;57:1259-1263.
6. Sgambato A, Zhang YJ, Arber N, et al. Deregulated expression of p27 in human breast cancer. Clin Cancer Res 1997;3:1879-1887.
7. Fredersdorf S, Burns J, Milne AM, et al. High levels of expression of p27 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27 and the degree of malignancies in human breast and colorectal cancer. Proc Natl Acad Sci USA 1997; 94:6380-6385.
8. Mommers ECM, van Diest PJ, Leonhart AM, et al. Expression of proliferation and apoptosis related proteins in usual ductal hyperplasia of the breast. Hum Pathol 1998;29:1539-1545.
9. Cariou S, Catzavelos C, Slingerland JM. Prognostic implication of expression of the cell cycle inhibitor protein p27 (Kip1). Breast Cancer Res Treat 1998;52:29-41.
10. Han S, Park K, Kim HY, et al. Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation. Breast Cancer Res Treat 1999;55:161-167.
11. Barbareschi M, van Tinteren H, Mauri FA, et al. p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up. Int J Cancer 2000;89:236-241
12. Tsuchiya A, Zhang G, Kanno M. Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node positive breast cancer. J Surg Oncol 1999;70:230-234.
13. Reed W, Floerenes VA, Holm R, et al. Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients. Virchow Arch 1999; 435:116-124.
14. Gilett CE, Smith P, Peters G, et al. Cyclin-dependent kinase inhibitor p27 (Kip1) expression and interaction with other cell cycle associated proteins in mammary carcinoma. J Pathol 1999;187:200-2007.
15. De Paola F, Vecci AM, Granato AM, et al. P27/Kip1 expression in normal epithelium, benign and neoplastic breast lesions. J Pathol 2002;196:26-31.
16. Chiarlie R, Pagano M, Inghirami G. The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer. Breast Cancer Res 2001;3:91-94.
17. Ball HM-L, Hupp TR, Ziyaie CA, et al. Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vitro monitoring. Br J Cancer 2001;85:1102-1105.
18. Troncone G, Fulciniti F, Zeppa P, et al. Cyclin dependent kinase inhibitor p27 expression in thyroid cells obtained by fine needle aspiration biopsy: a preliminary report. Diagn Cytopathol 2000;23:77-81.
19. Robinson IA, Mckee G, Nicholson A, et al. Prognostic value of cytological grading of fine needle aspirates from breast carcinomas. Lancet 1994;343:947-949.
20. Tafjord S, Bøhler PJ, Risberg B, et al. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol 2002;26:137-141.
21. Troncone G, Zeppa P, Fulciniti F, et al. c-erbB2 expression in FNAB smears and matched surgical specimens of breast cancer. Diagn Cytopathol 1996;14:135-139.
22. Colecchia M, Frigo B, Zucchi A, et al. p53 protein expression in fine-needle aspirates of breast cancer: an immunocytochemical assay for identifying high grade ductal carcinomas. Diagn Cytopathol 1995; 13:128-133.
23. Troncone G, Zeppa P, Vetrani A, et al. Bcl-2 protein in breast cancer cell obtained by fine needle aspiration biopsy (FNA): a preliminary report. Cytopathology 1995;6:174-180.
24. Dalquen P, Baschiera B, Chaffard R, et al. MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears. Acta Cytol 1997; 41:229-237.
25. Park K, Han S, Kim HY, et al. Cytologic evaluation of cyclin D1 expression in primary breast carcinoma. Cancer Cytopathol 2001;93:211-215.